Advanced/metastatic colorectal adenocarcinoma

Clinical trials for Advanced/metastatic colorectal adenocarcinoma explained in plain language.

Never miss a new study

Get alerted when new Advanced/metastatic colorectal adenocarcinoma trials appear

Sign up with your email to follow new studies for Advanced/metastatic colorectal adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Hard-to-Treat colorectal cancer: targeted drug enters human trials

Disease control Recruiting now

This early-stage trial tests a new drug, BAY 3771249, that targets a specific cancer-driving mutation called KRAS G12D. It is for people with advanced or metastatic colorectal cancer who have this mutation and have tried other treatments. The drug is given alone or with another c…

Matched conditions: ADVANCED/METASTATIC COLORECTAL ADENOCARCINOMA

Phase 1 • Sponsor: Bayer • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

Advanced/metastatic colorectal adenocarcinoma

Get alerted when new Advanced/metastatic colorectal adenocarcinoma trials appear

New hope for Hard-to-Treat colorectal cancer: targeted drug enters human trials